• Dietary Fiber Benefits
    • Blood Sugar
    • Calcium
    • Digestive Health
    • Infant Nutrition
    • Prebiotics
    • Weight Management
  • Physiological Impact
    • Digestive Health – Regularity
    • Infants, Prebiotics, and Digestive Health
    • Prebiotics and the Microbiota
    • Infant Nutrition and Immunity
    • Support Weight Management with Chicory Root Fiber
    • Increase of Calcium Absorption to Increase Bone Mineral Density
    • Blood Glucose Management
  • Ask the Experts
  • What’s New?
  • Research
  • About Us

Digestive Health – Regularity

November 19, 2015
by David Bouckaert
Comments are off

Digestive health is important to consumers. In a U.S. survey, 61 percent of consumers reported concern about maintaining digestive health and 43 percent were actively looking for products with natural ingredients to support that goal.

Is Constipation Common?

Many people experience bowel irregularity and constipation. Although individuals may define it in different ways, constipation can be described as fewer than three bowel movements a week and/or hard, dry and small bowel movements that are painful or difficult to pass (NIDDK). Constipation affects individuals of all ages. A seven-country survey found that more than one in five women in the U.S. and nearly one in six men described themselves as constipated (Wald et al, 2008). Between 2006 and 2011, constipation-related visits to emergency rooms by infants, children and adults across the U.S. rose 41.5 percent and mean cost per patient rose 56.4 percent (Sommers et al, 2015). Constipation can negatively influence feelings of well-being and quality of life.

The Role of the Colon

The large intestine, or colon, plays a major role in the regularity of bowel movements. Chyme moves from the small intestine into the colon in the final absorptive stage prior to elimination. Two major processes lead to production of feces from chyme: re-absorption of water and bacterial breakdown of fermentable undigested food residues. During re- absorption, up to 2 liters of chyme become concentrated into 0.5 liters of stool. The fermentation by bacteria of carbohydrates, primarily specific fibers, to generate short-chain fatty acids (SCFAs) is considered beneficial and desirable. Any undigested compounds that remain after fermentation, along with water and bacterial biomass, are excreted as a bowel movement. Adequate dietary fiber helps promote regularity, but the functionality of individual fibers need to be scientifically proven as not all fibers are the same.

Fiber and the Microbiome

Certain types of fiber, including the inulin-type fructans from inulin and oligofructose from chicory root, resist digestion in the small intestine, reach the large intestine virtually intact, and are metabolized by bacteria in the colon. Functioning as prebiotics, the non-digestible carbohydrates inulin and oligofructose selectively stimulate the growth and/or activity of beneficial bacteria such as bifidobacteria (Kleessen et al, 1997; Bouhnik et al, 2004; Kolida et al, 2007; Marteau et al, 2011; Mendlik et al, 2012) and lactobacilli (Ten Bruggengate et al, 2006), thus improving the health of the microbiome and contributing to normobiosis. (The opposite condition, dysbiosis, occurs when the microbiome is dominated by one or more potentially harmful bacterial species.) Other types of fiber are not used as feed for the microbiota to any significant degree and are excreted as such.

Chicory Root Fiber and Colon Function

Inulin and oligofructose catalyze both chemical and mechanical changes that enhance colon motility. Bifidobacteria and other beneficial bacteria are nourished by these fibers and selectively ferment them into SCFAs, including butyrate and acetaldehyde (De Preter et al, 2013). The presence of chicory root fiber (inulin, oligofructose) and the results of the prebiotic fermentation, SCFAs, in the large intestine contributes to softening by encouraging water binding in the stool and stimulates peristaltic muscle contraction. This leads to a slight increase in stool frequency per week, relief of mild constipation, increase in stool weight, and improvements in stool consistency, that is, softening. A meta-analysis of five studies involving 252 subjects showed significant effects on stool frequency, consistency, and transit time (Collado Yurrita L, et al, 2014).

Effects of inulin and oligofructose on stool frequency are well-documented in over two dozen studies on adults, older adults, and children, with effects resulting from a dosage of at least 3 g/day (Isakov et al 2013). Gibson et al. (1995) demonstrated that 15 g/day of oligofructose or inulin significantly increased stool frequency from 5.7 to 7.4 weekly bowel movements in healthy individuals. Stool weight went up 1.2 g and 2.1 g per gram of oligofructose or inulin, respectively. Later studies support the mild effects of inulin-type fructans on stool frequency, leading to more regular bowel movements among both healthy (Brighenti et al., 1999; Menne et al., 2000; Scholtens et al., 2006) and constipated (Kleessen et al, 1997; den Hond et al, 2000; Marteau et al, 2011) individuals. Effects on regularity do not appear to result from changes in transit time (Gibson et al., 1995; Causey et al., 2000; van Dokkum et al., 1999; Den Hond et al., 2000).

The increased biomass that results from exposure to inulin and oligofructose adds bulk to the fecal mass (Gibson et al, 1995; Castiglia-Delavaud et al, 1998; Den Hond et al., 2000; Van Dokkum et al., 1999; Scholtens et al., 2006 ). Furthermore, the higher water content of the biomass increases moisture in the stool and acts as a softening agent (Mendlik et al, 2012). As a result, excretion is facilitated.

Oligofructose also may aid those at risk of developing diarrhea. Cummings et al. (2001) provided a small group of healthy individuals at risk for travelers’ diarrhea with 10 g/day of oligofructose. The travelers taking oligofructose experienced a small but significant increase in frequency of bowel movements, a decrease in incidence of diarrhea (not significant), and significantly improved feelings of well-being.

Benefits to Infants and Children

Breast-fed infants have loose stools due to the human milk oligosaccharides (undigestible carbohydrates). When analyzing the microbiota composition, bifidobacteria are the dominating microorganisms. Prebiotics (Oligofructose (FOS), Orafti®Synergy1, GOS) are added to bottle-fed formula for infants to get the physiological effects of that formula closer to that of breast-fed children. In a randomized, double-blind, placebo-controlled trial on 56 infants under one year of age, Moore et al. (2003) observed an increase in stool frequency from 1.58 to 1.99 times per day and a softened stool consistency after feeding between 0.75 and 3g/day of oligofructose or control (maltodextrin) over 4 weeks. Supplementation of an average of 1.1 g/day oligofructose decreased constipation in a group of 123 infants and toddlers ages 4-24 months (Saavedra, 2002). A group of 35 infants and toddlers receiving 2 g/day oligofructose as part of a randomized, double-blind, placebo-controlled intervention study experienced significantly less flatulence and diarrhea (Waligora-Dupriet et al, 2007).

Desirable changes in stool consistency also were observed in a group of 2-5 year-old children with functional constipation (Escribano et al, 2015). Closa et al (2013) studied the effect of Orafti®Synergy1 (oligofructose-enriched inulin) provided in infant formula (0.8g/dL) in infants during the first 4 months of life in a double-blind, randomized, placebo-controlled and parallel trial with 124 control (Maltodextrin), 128 Orafti®Synergy 1 fed infants and 131 infants that were breast-fed. The safe use of oligofructose-enriched inulin was clearly demonstrated in this study. The Syn1 infants showed a microbiota composition closer to breast-fed infants, softer stools and a higher stool frequency compared to controls, positioning the babies closer to breast-fed babies in their digestive health parameters.

Global Acceptance of the Relationship Between Chicory Root Fiber and Supporting a Normal Bowel Function

Inulin and oligofructose support digestive health, i.e. they support normal bowel function by increasing stool frequency per week, by providing relief in constipated people, by softening stools and provide higher stool weight. The dosage of inulin and oligofructose associated with digestive health varies with individual differences and subjective perception of digestive health and gastrointestinal tolerance. In human intervention studies intake amounts vary between 40g/d and 3g/d. Overall it can be concluded that a daily intake of approximately 8g/d taken in various occasions during the day (e.g. 2 g per serving) will support normal bowel function. In addition to their relationship with gastrointestinal health, inulin-type fructans can help fill in the fiber gap in the U.S., with few Americans meeting the recommendations of 38 grams per day for adult men and 25 grams per day for women (IOM 2005; What We Eat in America; Dietary Guidelines for Americans, 2010).

 

References

Bouhnik Y, et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr. 2004; 80: 1658-1664. http://ajcn.nutrition.org/content/80/6/1658.long

Brighenti F, et al. Effect of consumption of a ready-to-eat-breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr. 1999; 53: 726-33. http://www.ncbi.nlm.nih.gov/pubmed/10509770

Castiglia-Delavaud C, et al. Net energy value of non-starch polysaccharide isolates (sugarbeet fibre and commercial inulin) and their impact on nutrient digestive utilization in healthy human subjects. Br J Nutr. 1998; 80:343-52. http://www.ncbi.nlm.nih.gov/pubmed/9924276

Causey JL, et al. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res. 2000; 2:191-201.

Closa-Monasterolo, R., Gispert-Llaurado, M., Luque, V., Ferre, N., Rubio-Torrents, C., Zaragoza-Jordana, M., Escribano, J. (2013) Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial. Clin Nutr 32, 918–927.

Collado Yurrita L, et al. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials. Nutr Hosp. 2014; 39:244-52. http://www.aulamedica.es/nh/pdf/7565.pdf

Cummings, J.H., Christie, S., Cole, T.J. (2001) A study of fructo oligosaccharides in the prevention of travellers’ diarrhoea. Aliment Pharmacol Ther 15, 1139–1145.

De Preter V, et al. Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn’s disease patients: a double-blinded randomized controlled trial. Clin Transl Gastroenterol. 2013 Jan 10;4:e30.  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561595/

Den Hond E, et al. Effect of high performance chicory inulin on constipation. Nutr Res. 2000; 20:731–736.

Scientific Opinion on the substantiation of a health claim related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924/2006. EFSA Journal. 2015; 13:3951. http://www.efsa.europa.eu/en/efsajournal/pub/3951.htm

Escribano FN, et al. (2015) The use of inulin-type fructans improves stool consistency in constipated children. A pilot study. ESPGHAN2015-1454.

Gibson, G.R., Beatty, E.R., Wang, X., Cummings, J.H. (1995) Selective Stimulation of Bifidobacteria in the Human Colon by Oligofructose and Inulin. Gastroenterology 108, 975–982. http://www.ncbi.nlm.nih.gov/pubmed/7698613 

Isakov, V., Pilipenko, V., Shakhovskaya, A., Tutelyan, V. (2013) Effect of inulin enriched yogurt on bowel habits in patients with irritable bowel syndrome with constipation: a pilot study. FASEB J 27; Ib426.

Kleessen B, et al. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr. 1997;65:1397-402. http://ajcn.nutrition.org/content/65/5/1397.long

Kolida S, et al. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr. 2007; 61:1189-95. http://www.nature.com/ejcn/journal/v61/n10/full/1602636a.html

Marteau P, et al. Effects of chicory inulin in constipated elderly people: a double-blind controlled trial. Int J Food Sci Nutr. 2011; 62:164-70. http://informahealthcare.com/doi/abs/10.3109/09637486.2010.527323

Mendlik K, et al. Effects of fructooligofructoses chain length on the bifidobacteria of the human colon: a pilot study. Food and Nutrition Sciences. 2012; 3(12): 1615-18. http://www.scirp.org/journal/PaperInformation.aspx?PaperID=25263

Menne N, et al. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J Nutr. 2000; 130: 1197-9. http://jn.nutrition.org/content/130/5/1197.long

Moore N, et al. Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. Brit J Nutr. 2003; 90: 581-7. http://www.ncbi.nlm.nih.gov/pubmed/13129464

National Institute of Diabetes and Digestive and Kidney Diseases. Constipation. http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/constipation/Pages/overview.aspx. Accessed July 23, 2015.

Saavedra, J.M., Tschernia, A. (2002) Human studies with probiotics and prebiotics: clinical implications. Br J Nutr 87 Suppl 2, S241. http://www.ncbi.nlm.nih.gov/pubmed/12088524

Scholtens PA, et al. Dietary fructo-oligosaccharides in healthy adults do not negatively affect fecal cytotoxicity: a randomised, double-blind, placebo-controlled crossover trial. Br J Nutr. 2006; 95:1143-9. http://www.ncbi.nlm.nih.gov/pubmed/16768837

Sommers T, et al. Emergency department burden of constipation in the United States from 2006 to 2011. Am J Gastroenterol. 2015; 110(4):572-9. http://www.ncbi.nlm.nih.gov/pubmed/25803399

Ten Bruggencate SJ, et al. Dietary fructooligosaccharides affect intestinal barrier function in healthy men. J Nutr. 2006;136: 70-4. http://jn.nutrition.org/content/136/1/70.

van Dokkum W, et al. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr. 1999; 53:1-7. http://www.ncbi.nlm.nih.gov/pubmed/10048793

Wald A, et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther. 2008;28:917-30. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2008.03806.x/abstract;jsessionid=8478A302C686C501CDE4FBDE7C8331A8.f01t02

Waligora-Dupriet AJ, et al. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int J Food Microbiol. 2007; 113:108-13. http://www.ncbi.nlm.nih.gov/pubmed/16996154

Social Share

    Recent Articles

    Chicory Root
    Chicory root fiber is a prebiotic. But what exactly is a prebiotic?
    Feb 08, 2023
    How do prebiotics, in particular chicory root fiber, influence the metabolism?
    Aug 13, 2018
    Can the microbiota prevent obesity and metabolic diseases?
    Aug 13, 2018
    How a healthy gut microbiota can help you eat less and improve your metabolism
    Jul 20, 2018
    What is Chicory Root?
    Apr 05, 2016
    Copyright © 2019 BENEO-Institute     Privacy Policy      Imprint
    This page is brought to you courtesy of the BENEO-Institute.